The divestiture is a modest deleveraging event that provides ~$107M in net cash proceeds, but the $55M pre-tax loss on sale and loss of $415M in annual revenue (~3.3% of total) suggest the assets were sold at a discount to carrying value. Monitor the post-closing working capital adjustment for potential further cash impact. The sale reduces CYH's geographic footprint but does not materially change the company's leverage profile (pro forma long-term debt remains $10.127B). Watch for additional hospital divestitures as CYH continues its portfolio rationalization strategy.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 2 $2.78entry
- T+1 · 6mo ago +0.72%α +1.44% · $2.80
- T+5 · 5mo ago +3.24%α +6.20% · $2.87
- T+20 · 5mo ago +27.34%α +28.90% · $3.54
- T+60 · 3mo ago +5.04%α +3.92% · $2.92
Price Chart
How similar events traded
Executive Summary
Community Health Systems (CYH) completed the sale of four Arkansas hospitals (Northwest Medical Center - Bentonville, Northwest Medical Center - Springdale, Northwest Medical Center - Willow Creek Women's Hospital, and Siloam Springs Regional Hospital) and associated outpatient centers to Freeman Health System for $110 million in cash, subject to post-closing working capital adjustments. The transaction resulted in a pro forma pre-tax loss on sale of $55 million ($48 million after tax), and the divested operations generated approximately $415 million in annual revenue (3.3% of CYH's 2025 total revenue of $12.485 billion). The sale reduces CYH's hospital count from 64 to 60 affiliated hospitals and provides cash proceeds of ~$107 million net of transaction expenses, which will increase cash and cash equivalents to approximately $819 million on a pro forma basis.
Key Facts
- Completed sale of 4 Arkansas hospitals to Freeman Health System for $110 million in cash
- Purchase price after estimated working capital and finance lease assumption was $110 million, subject to post-closing adjustment
- Pro forma pre-tax loss on sale of $55 million ($48 million after tax)
- Divested operations generated ~$415 million in annual revenue (3.3% of CYH's total 2025 revenue of $12.485 billion)
- Net cash proceeds of ~$107 million after $3 million in transaction expenses
- Pro forma cash and cash equivalents increase to ~$819 million from $712 million
- CYH retains 60 affiliated hospitals post-divestiture (down from 64)
- Seller provided $78,614 credit for chiller repairs and $500,000 credit for environmental matters
- 3-year non-compete covenant within 40-mile radius of the hospitals
- Transition services agreements for IT, billing, and clinical operations post-closing
Financial Impact
Sale proceeds of $110 million cash; pro forma loss on sale of $55 million pre-tax ($48 million after tax); divested revenue of ~$415 million annually (3.3% of total); cash balance increases by ~$107 million net
Risk Factors
- Post-closing working capital adjustment could reduce net proceeds
- Loss of $415M in annual revenue may pressure future earnings comparisons
- Retained liabilities for pre-closing operations (medical malpractice, regulatory, tax) could result in future cash outflows
- Transition services agreements create operational complexity and potential disputes
- Environmental credits ($500K) may not fully cover remediation costs
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-251540 |
| Document: cyh-ex99_1.htm | 0001193125-26-251540 |
| Document: cyh-20260601.htm | 0001193125-26-251540 |
| Document: cyh-ex99_2.htm | 0001193125-26-251540 |
| Document: 0001193125-26-251540-index-headers.html | 0001193125-26-251540 |
| Document: 0001193125-26-251540-index.html | 0001193125-26-251540 |
| Document: 0001193125-26-251540.txt | 0001193125-26-251540 |
Track record
5 reports on CYH
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 9, 20267d ago 8-K Neutral 4/10 Entry $2.17 Now $2.13 −1.84% settles Nov 17
- Oct 28, 202619d ago 8-K Bearish 6/10 Entry $2.41 to $2.28 Now $2.13 +11.62% ▲ +5.39% +0.67% vs SPY
- Jun 1, 202624w ago 8-K Neutral 5/10 Viewing Entry $2.78 to $2.87 Now $2.13 −23.38% ▲ +3.24% +6.20% vs SPY
- Apr 21, 202629w ago 8-K Bearish 7/10 Entry $2.71 to $2.87 Now $2.13 +21.40% ▼ −5.90% −5.85% vs SPY
- Mar 5, 202636w ago 8-K Neutral 5/10 Entry $3.35 to $3.20 Now $2.13 −36.42% ▼ −4.48% −2.95% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers